Over the past 20 years, the level of globalisation in the
pharmaceutical industry increased significantly for both
innovative and generic drugs. Magdalena Matusiak,
Associate Director, Quality Assurance & Compliance at KCR,
analyses how international cooperation between regulatory
bodies and the harmonisation of regulatory requirements
are key elements supporting the effective development of
medicines.